Bivalirudin (CAS 128270-60-0): A High-Quality Synthetic Peptide for Angioplasty Intervention
Discover premium Bivalirudin powder, a potent direct thrombin inhibitor crucial for advanced angioplasty procedures. Ensure patient safety and procedural success.
Get a Quote & SampleUnlock Cardiovascular Health: The Core Value of Bivalirudin
Bivalirudin
Bivalirudin, with CAS No. 128270-60-0, is a highly refined synthetic peptide, mirroring parts of natural hirudin. It stands as a pivotal solution in medical interventions, offering a direct, specific, and reversible inhibition of thrombin, vital for managing coagulation effectively during critical procedures.
- Strategic Sourcing for Angioplasty: Secure your supply of high purity Bivalirudin powder, essential for critical cardiac interventions.
- Precision Thrombin Inhibition: Experience the benefits of a direct thrombin inhibitor Bivalirudin, ensuring controlled anticoagulant effects.
- Certified Quality & Efficacy: Our Bivalirudin meets stringent GMP and FDA standards, guaranteeing a reliable Bivalirudin anticoagulant API.
- Advanced Synthetic Peptide Technology: Benefit from a cutting-edge synthetic peptide with 20 amino acids, designed for optimal therapeutic outcomes.
Key Advantages of Choosing Premium Bivalirudin
Superior Anticoagulant Action
Bivalirudin acts as a direct thrombin inhibitor, providing precise and predictable anticoagulation crucial for procedures like angioplasty intervention treatment.
Assured Purity and Potency
Our high purity Bivalirudin powder is manufactured under strict GMP certified production guidelines, ensuring consistency and therapeutic effectiveness.
Reversible and Specific Inhibition
Unlike older alternatives, Bivalirudin offers highly specific and reversible inhibition, minimizing bleeding risks and improving patient safety during medical procedures.
Key Applications
Cardiac Catheterization
Bivalirudin is a preferred anticoagulant during percutaneous coronary intervention (PCI) and other cardiac catheterization procedures, ensuring smooth operations.
Acute Coronary Syndromes
For patients suffering from acute coronary syndromes, Bivalirudin CAS 128270-60-0 serves as a critical agent to prevent thrombotic complications.
Heparin-Induced Thrombocytopenia (HIT)
It is an invaluable alternative for patients with or at risk of heparin-induced thrombocytopenia, providing safe thrombin inhibition.
Vascular Procedures
Beyond cardiac uses, synthetic peptide thrombin inhibitor Bivalirudin is effective in various vascular procedures requiring controlled anticoagulation.